| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,791,875 | 898,197 | 785,646 | 1,939,957 | | Cost of Revenue | 873,260 | 492,137 | 439,774 | 1,047,791 | | | Gross Profit | 918,615 | 406,060 | 345,872 | 892,166 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 582,161 | 373,547 | 401,081 | 630,289 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
| 29,507 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 336,454 | 32,513 | (55,209) | 232,370 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (12,504) | 8,793 | 5,676 | 22,273 | | Earnings Before Interest And Taxes | 323,950 | 41,306 | (49,533) | 254,643 | | Interest Expense | 19,317 | 17,489 | 15,917 | 28,918 | | Income Before Tax | 304,633 | 23,817 | (65,450) | 225,725 | | Income Tax Expense | 74,791 | 2,348 | (14,464) | 49,324 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 229,842 | 21,469 | (50,986) | 176,401 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 229,842 | 21,469 | (50,986) | 176,401 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $229,842 | $21,469 | ($50,986) | $176,401 |
|
2.03% Nasdaq 
Income Statement
